This is a demo store. No orders will be fulfilled.

Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) - Primary antibody, specific to TNFRSF21, Human IgG1

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human,Rat
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab209901
Grouped product items
SKU Size
Availability
Price Qty
Ab209901-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$109.90
Ab209901-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$509.90
Ab209901-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,399.90
Ab209901-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,299.90

Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) - Primary antibody, specific to TNFRSF21, Human IgG1
Synonyms TNFRSF 21 antibody | BM 018 antibody | BM018 antibody | CD358 antibody | Death receptor 6 antibody | DR 6 antibody | DR6 antibody | MGC31965 antibody | OTTHUMP00000039915 antibody | TNFR related death receptor 6 antibody | TNFRSF21 antibody | TNFRSF21 pro
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Biochemical and Physiological Mechanisms May activate NF-kappa-B and promote apoptosis. May activate JNK and be involved in T-cell differentiation. Required for both normal cell body death and axonal pruning. Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to re
Host species Human
Specificity TNFRSF21
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Product Description

Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) is a humanized monoclonal antibody that specifically targets TNFRSF21. It can be used in treatment of cancer.

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 150 kDa
Purification Method Protein A purified
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.

Associated Targets(Human)

TNFRSF21 Tbio Tumor necrosis factor receptor superfamily member 21 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Images

Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) (Ab209901) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling TNFRSF21 (red) with Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) (Ab209901) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) (Ab209901) - Flow Cytometry
Flow Cytometry analysis of Raji cells labelling TNFRSF21 (red) with Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) (Ab209901) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) (Ab209901) - Flow Cytometry
Flow Cytometry analysis of huDR6-FL-HEK293-A6 cells labelling TNFRSF21 at 1×105 cell/well can bind  Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) (Ab209901), with the EC₅₀ is 0.593 nM.

Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) (Ab209901) - SEC
The purity of Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) (Ab209901) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.